Search Results - "Postorino, Elisa Imelde"
-
1
Use of allogeneic platelet-rich plasma for the treatment of autoimmune ocular surface disorders: case series
Published in Frontiers in ophthalmology (2023)“…To assess the effectiveness of topical allogeneic platelet-rich plasma (PRP) eye drops for the treatment of symptoms and clinical signs in patients with severe…”
Get full text
Journal Article -
2
Observational Clinical Investigation Evaluating an Ophthalmic Solution Containing Xanthan Gum and Low Concentration Desonide Phosphate in Dry Eye Disease Treatment
Published in Ophthalmology and therapy (01-10-2024)“…Introduction Patients with dry eye disease (DED) complain of a multitude of symptoms that affect their visual function and quality of life (QoL). This clinical…”
Get full text
Journal Article -
3
-
4
Post-surgical management of cataract: Light and dark in the 2020s
Published in European journal of ophthalmology (01-03-2021)“…Cataract surgery is the most frequently performed elective surgery worldwide. Although considered a safe procedure, potentially sight-threatening adverse…”
Get full text
Journal Article -
5
Ophthalmologic Manifestations of Primary Sjögren's Syndrome
Published in Genes (04-03-2021)“…Sjögren's syndrome (SS) is a chronic, progressive, inflammatory, autoimmune disease, characterized by the lymphocyte infiltration of exocrine glands,…”
Get full text
Journal Article -
6
Early Corneal Innervation and Trigeminal Alterations in Parkinson Disease: A Pilot Study
Published in Cornea (01-04-2018)“…PURPOSE:To describe corneal innervation and trigeminal alterations in drug-naive patients with Parkinson disease (PD). METHODS:A case series study was…”
Get full text
Journal Article -
7
Changes in conjunctival epithelial cells after treatment with 0.2% xanthan gum eye drops in mild-moderate dry eye
Published in European journal of ophthalmology (01-05-2020)“…Purpose: To study the effects of xanthan gum eye drops on the ocular surface and conjunctival cytology of patients with mild-moderate dry eye. Methods: This…”
Get full text
Journal Article -
8
Clinical Efficacy, Tolerability and Safety of a New Multiple-Action Eyedrop in Subjects with Moderate to Severe Dry Eye
Published in Journal of clinical medicine (26-11-2022)“…Background: To assess the clinical efficacy, tolerability and safety of a new-generation ophthalmic solution containing cross-linked hyaluronic acid 0.15%…”
Get full text
Journal Article -
9
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies
Published in Investigative ophthalmology & visual science (01-05-2016)“…To investigate corneal confocal microscopic changes in nonneoplastic and neoplastic monoclonal gammopathies. Three groups of subjects were considered: group 1,…”
Get full text
Journal Article -
10
High-Tech Parameters for the Evaluation of Signs and Symptoms of Dry Eye Disease: Identification of Clinical Cut-Offs and Agreement with Low-Tech Tests
Published in Ophthalmology and therapy (01-11-2024)“…Introduction High-tech devices for the assessment of dry eye disease (DED) are increasingly available. However, the agreement between high- and low-tech…”
Get full text
Journal Article -
11
Effectiveness of a New Active Tear Substitute Containing 0.2% Hyaluronic Acid and 0.001% Hydrocortisone on Signs and Symptoms of Dry Eye Disease by Means of Low- and High-Tech Assessments
Published in Ophthalmology and therapy (01-01-2024)“…Introduction An innovative eye drops formulation containing 0.2% hyaluronic acid and a low concentration of hydrocortisone (0.001%; hereafter HALH) has been…”
Get full text
Journal Article